Nucleus Capital is a first-check deep-tech VC firm that backs scientific ventures at the earliest stages. They are driven by the belief that founder-led innovation is vital to creating a future worth inheriting. Their focus lies on deep-tech solutions for planetary resilience. The firm operates as thesis-driven, high conviction investors with a concentrated portfolio active in Europe and the US. They recognize that deep-tech ventures require a different approach than SaaS companies, and have built a support model tailored to the pace, complexity, and capital needs of breakthrough innovation. Nucleus Capital invests selectively and commits fully, providing portfolio companies access to an ecosystem of industry-specific expertise, commercial networks, and strategic support. They focus on purpose-driven teams solving systemic challenges on a global scale.
Preferred startup development maturity for initial funding deployment.
Programmable biology, Food technology, Neo industrials
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...